gabapentin has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 3 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakamura, K | 1 |
Yoshida, K | 1 |
Miyazaki, D | 1 |
Morita, H | 1 |
Ikeda, S | 1 |
Gazulla, J | 2 |
Tintoré, MA | 1 |
Tintoré, M | 1 |
1 review available for gabapentin and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
The P/Q-type voltage-dependent calcium channel: a therapeutic target in spinocerebellar ataxia type 6.
Topics: Amines; Anticonvulsants; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cyclohexanecar | 2007 |
1 trial available for gabapentin and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
Spinocerebellar ataxia type 6 (SCA6): clinical pilot trial with gabapentin.
Topics: Adult; Aged; Amines; Brain; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Female; Gabapenti | 2009 |
1 other study available for gabapentin and Autosomal Dominant Cerebellar Ataxia, Type II
Article | Year |
---|---|
The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: gabapentin and pregabalin may be of therapeutic benefit.
Topics: Amines; Calcium Channel Blockers; Calcium Channels, P-Type; Calcium Channels, Q-Type; Cyclohexanecar | 2007 |